Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Omid Seidizadeh et al, published in Nature Scientific Reports, adding:
”How common is von Willebrand disease?
Far more prevalent than registries indicate.
A new Nature study uses gnomAD v4.1 (807,000+ sequenced individuals) and Hardy–Weinberg genetic modeling on 321 pathogenic/likely pathogenic VWF variants to refine the global genetic prevalence of von Willebrand disease (VWD).
By filtering 10,397 VWF variants down to this high‑confidence pathogenic set and applying Hardy–Weinberg models, the authors report a strikingly high global prevalence:
- approximately 11 per 1,000 for type 1 (≈1.1% of the population)
- 1.3–1.7 per 1,000 for dominant type 2 variants (2A, 2B, 2M)
- Tens per million for recessive forms (≈34 per million for 2N and ≈1–2 per million for type 3)
- Altogether, this translates into tens of millions of affected individuals worldwide.
The study further maps pathogenic variant clustering across functional VWF domains and highlights ancestry‑specific distributions of key alleles, underscoring both shared VWF biology and population‑specific risk patterns.
For clinical and research practice, these data provide a valuable reference for variant interpretation, support more realistic registry and screening strategies, and reinforce that VWD—particularly mild and qualitative forms—remains substantially underdiagnosed and undertreated.
Congratulations to Omid Seidizadeh, Andrea Cairo, Camilla Oriani and Flora Peyvandi.”
Title: Updated global prevalence and ethnic diversity of von Willebrand disease based on population genetics analysis
Authors: Omid Seidizadeh, Andrea Cairo, Camilla Oriani, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 09:49Manuel Monreal: Acute VTE in Patients With Severe Renal Insufficiency
-
Sep 26, 2026, 09:38New TIF Guidelines for Emergency Care in Thalassaemia and SCD
-
Sep 26, 2026, 09:28Annette Bowyer: Rethinking Product Specific Calibrators in Haemophilia
-
Sep 26, 2026, 09:21Nisanth Menon: When Emergency Medicine Meets Transfusion Medicine
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory